Worldwide Study Finder

Loading registry information…

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:58 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

HUMAN CHORIONIC GONADOTROPIN (HcG) VS MAGNESIUM SULPHATE (MgSo4) AS A TOCOLYTIC AGENT- A RANDOMIZED CONTROLLED TRIAL

ClinicalTrials.gov · NCT05828966 · Registry updated: 2024-06-07

Condition / research focus: Preterm Labor
Sponsor: Shaheed Zulfiqar Ali Bhutto Medical University
Countries with listed sites: Pakistan
Registry dates and results: Start: 2023-02-15. Completion: 2023-12-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human chorionic gonadotropin (hCG) (drug)
Magnesium sulfate (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Mother and Child Care Hospital, Shaheed Zulfiqar Ali Bhutto Medical UniversityIslamabad, Pakistan

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Phase 3CompletedINTERVENTIONAL

Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)

ClinicalTrials.gov · NCT03019575 · Registry updated: 2024-05-23

Condition / research focus: Hypogonadotropic Hypogonadism
Sponsor: Organon and Co
Countries with listed sites: Brazil · Denmark · Italy · Mexico · Russia · South Africa
Registry dates and results: Start: 2017-02-02. Completion: 2020-05-05 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Corifollitropin alfa (drug) — also listed as: MK-8962, Elonva
hCG (drug)

Where the study takes place — 15 listed sites

Centro de Diabetes Curitiba ( Site 0012)
Curitiba, Brazil
Site recruitment: Not reported
Hospital de Clinicas de Porto Alegre ( Site 0014)
Porto Alegre, Brazil
Site recruitment: Not reported
Hosp das Clinicas da Faculdade de Medicina da Univ de Sao Paulo ( Site 0015)
São Paulo, Brazil
Site recruitment: Not reported
Rigshospitalet, University department of Growth and Reproduction ( Site 0051)
Copenhagen, Denmark
Site recruitment: Not reported
AOU Careggi ( Site 0042)
Florence, Italy
Site recruitment: Not reported
Policlinico Umberto I ( Site 0043)
Roma, Italy
Site recruitment: Not reported
IRCCS Ospedale Pediatrico Bambino Gesu ( Site 0044)
Roma, Italy
Site recruitment: Not reported
Instituto Nacional de Pediatria ( Site 0007)
Mexico City, Mexico
Site recruitment: Not reported
Hospital Infantil de Mexico Federico Gomez ( Site 0006)
Mexico City, Mexico
Site recruitment: Not reported
Kazan State Medical University ( Site 0024)
Kazan', Russia
Site recruitment: Not reported
Federal State Budget Institution Endocrinological Research Center ( Site 0021)
Moscow, Russia
Site recruitment: Not reported
City children polyclinic #44 ( Site 0025)
Saint Petersburg, Russia
Site recruitment: Not reported
St.Petersburg State Pediatric Medical University ( Site 0023)
Saint Petersburg, Russia
Site recruitment: Not reported
Republic Children Clinical Hospital ( Site 0022)
Ufa, Russia
Site recruitment: Not reported
Little Company of Mary Hospital ( Site 0017)
Pretoria, South Africa
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Worldwide Study Finder

Worldwide Study Finder

Find a study

Registry search results

HUMAN CHORIONIC GONADOTROPIN (HcG) VS MAGNESIUM SULPHATE (MgSo4) AS A TOCOLYTIC AGENT- A RANDOMIZED CONTROLLED TRIAL

Explore the world’s study registries

Worldwide

Africa

Americas

A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)

Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)

Double Pick up in Poor Prognosis Women

Ejaculation Abstinence Time and Assisted Reproductive Technology Outcomes

Analysis of the Composition of the Vaginal Microbiota During IVF Treatment and Correlation With Serum Progesterone Level on the Day of Embryo Transfer

Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus

Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer

Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol

Comparison of Recombinant Follicle Stimulating Hormone and the Combination of Recombinant Follicle Stimulating Hormone With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles

Clinical Trail of the Lay User Study and Method Comparison Study of Human Chorionic Gonadotropin (HCG) Test System

Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles

Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD

Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve

The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger

Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS

HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients

Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration

Ovarian Contribution to Androgen Production in Adolescent Girls

Asia

Middle East

Europe

Oceania